1. Allignol, A., Beyersmann, J., & Schmoor, C. (2016). Statistical issues in the analysis of adverse events in time-to-event data. Pharmaceutical Statistics, 15, 297–305.
2. Amit, O., Heiberger, R. M., & Lane, P. W. (2008). Graphical approaches to the analysis of safety data from clinical trials. Pharmaceutical Statistics, 7, 20–35.
3. Battioui, C., Shen, L., & Ruberg, S. J. (2013). A resampling-based ensemble tree method to identify patient subgroups with enhanced treatment effect. In Proceedings to the Joint Statistical Meetings.
4. Bender, R., Beckmann, L., & Lange, S. (2016). Biometrical issues in the analysis of adverse events within the benefit assessment of drugs. Pharmaceutical Statistics, 15, 292–296.
5. Benjamini, Y., & Hochberg, Y. (1995). Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society B, 57, 289–300.